Coherus and Junshi Biosciences Announce FDA Approval of LOQTORZI™ (toripalimab-tpzi ...

Antineoplastic drugs

Orphan drugs

Breakthrough therapy

Cancer treatments

Cancer immunotherapy

TIGIT

Checkpoint inhibitor

Chemotherapy

Enteropathy-associated T-cell lymphoma

Treatment of lung cancer

Durvalumab

Shanghai

Gemcitabine

shanghai junshi biosciences co., ltd.

Coherus Biosciences Inc.

United States

China

Cisplatin

u.s. food and drug administration

Coherus and Junshi Biosciences Announce FDA Approval of LOQTORZI™ (toripalimab-tpzi .... View article details on HISWAI: https://pipelinereview.com/index.php/2023102884595/Antibodies/Coherus-and-Junshi-Biosciences-Announce-FDA-Approval-of-LOQTORZI-toripalimab-tpzi-in-All-Lines-of-Treatment-for-Recurrent-or-Metastatic-Nasopharyngeal-Carcinoma-NPC.html